Euromed was founded in 1971 by the German pharmaceutical group Madaus, with the aim of supplying the best quality materials for their leading phytopharmaceutical products, such as milk thistle (Silybum marianum L.) seed extract, indicated for liver health support. Plantations were established and the supply chain is vertically integrated. Since then, Euromed has constantly improved the supply chain, the quality control and production technologies to provide premium standardized botanical extracts.
Several steps are involved, including analytical, agronomical and botanical research projects, that lead to development of improved cultivation methods and thus final extracts.
Decades of experience are available to global pharmaceutical and health ingredients industries seeking consistent standardization of every production batch, full traceability, identity, purity, safety and evidence-based efficacy.
In summer 2018 Euromed inaugurated its new Research & Innovation Center in Barcelona, with the objective to bolster its established leading position in producing pharmaceutical grade botanical extracts, with state-of-the-art technologies and obtained with sustainable agricultural and collection practices.
Annually, more than 5,000 tons of biomass are extracted at two manufacturing plants in Spain, complying with pharmacopoeias and the highest international regulatory standards.
- Hydro-Pure Process
- American Botanical Council (ABC)
- American Herbal Products Association (AHPA)